Matrix Capital Management Company, LP - Q2 2022 holdings

$4.41 Billion is the total value of Matrix Capital Management Company, LP's 20 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 28.0% .

 Value Shares↓ Weighting
TDG  TRANSDIGM GROUP INC$587,600,000
-17.6%
1,094,9000.0%13.32%
+55.5%
BuyGLOBALFOUNDRIES INCordinary shares$507,974,000
-11.3%
12,592,309
+37.2%
11.51%
+67.4%
CRWD  CROWDSTRIKE HLDGS INCcl a$505,680,000
-25.8%
3,000,0000.0%11.46%
+40.1%
ALTR BuyALTAIR ENGR INC$488,250,000
-11.8%
9,300,000
+8.1%
11.06%
+66.4%
QCOM  QUALCOMM INC$426,314,000
-16.4%
3,337,3600.0%9.66%
+57.8%
NFLX  NETFLIX INC$349,740,000
-53.3%
2,000,0000.0%7.93%
-11.9%
AMAT  APPLIED MATLS INC$292,319,000
-31.0%
3,213,0000.0%6.62%
+30.3%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$258,519,000
+28.8%
9,199,973
+111.5%
5.86%
+143.2%
TWLO BuyTWILIO INCcl a$248,710,000
-42.3%
2,967,549
+13.4%
5.64%
+8.9%
MU  MICRON TECHNOLOGY INC$221,120,000
-29.0%
4,000,0000.0%5.01%
+34.0%
WDAY  WORKDAY INCcl a$156,475,000
-41.7%
1,121,0430.0%3.55%
+10.1%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$93,622,000
-41.7%
11,572,5900.0%2.12%
+10.1%
 PERIMETER SOLUTIONS SA$80,894,000
-10.5%
7,462,5000.0%1.83%
+68.9%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$66,256,000
-17.5%
38,974,1850.0%1.50%
+55.8%
 AURA BIOSCIENCES INC$58,279,000
-35.6%
4,112,8700.0%1.32%
+21.6%
CRM SellSALESFORCE INC$52,235,000
-90.6%
316,500
-87.9%
1.18%
-82.3%
NewWOLFSPEED INC$6,345,000100,000
+100.0%
0.14%
BuyIMAGO BIOSCIENCES INC$4,834,000
-18.6%
361,000
+17.2%
0.11%
+54.9%
 VENTYX BIOSCIENCES INC$4,097,000
-9.9%
335,0000.0%0.09%
+69.1%
ADCT  ADC THERAPEUTICS SA$3,180,000
-45.9%
400,0000.0%0.07%
+1.4%
ARKG ExitARK ETF TRgenomic rev etf$0-1,000,000
-100.0%
-0.55%
S ExitSENTINELONE INCcl a$0-2,250,000
-100.0%
-1.05%
XBI ExitSPDR SER TRs&p biotech$0-2,100,000
-100.0%
-2.27%
NEWR ExitNEW RELIC INC$0-5,000,000
-100.0%
-4.01%
AMD ExitADVANCED MICRO DEVICES INC$0-3,619,140
-100.0%
-4.75%
DIS ExitDISNEY WALT CO$0-6,330,000
-100.0%
-10.42%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC42Q3 202313.3%
WORKDAY INC42Q3 202319.7%
NETFLIX INC37Q2 202226.1%
NEW RELIC INC29Q1 20227.8%
DAVITA INC26Q3 20196.1%
ADAPTIMMUNE THERAPEUTICS PLC26Q3 20236.8%
SALESFORCE INC23Q3 202218.4%
CONSTELLATION BRANDS INC23Q2 20195.7%
AMAZON COM INC21Q3 202311.2%
TABLEAU SOFTWARE INC20Q2 201915.2%

View Matrix Capital Management Company, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Matrix Capital Management Company, LP Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adaptimmune Therapeutics PLCJuly 10, 2023233,845,11017.3%
Zentalis Pharmaceuticals, Inc.June 20, 202313,959,97319.8%
ForgeRock, Inc.Sold outFebruary 13, 202300.0%
NEW RELIC, INC.Sold outFebruary 13, 202300.0%
Perimeter Solutions, SAFebruary 13, 20238,587,5005.4%
Aura Biosciences, Inc.December 07, 20225,362,87014.5%
Adaptive Biotechnologies CorpFebruary 14, 202211,572,5908.2%
BigCommerce Holdings, Inc.Sold outFebruary 14, 202200.0%
CarGurus, Inc.Sold outFebruary 16, 202100.0%
Trillium Therapeutics Inc.Sold outFebruary 14, 202000.0%

View Matrix Capital Management Company, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
42023-11-09
SC 13D/A2023-11-09
13F-HR2023-08-14
SC 13G/A2023-07-10
42023-06-20
SC 13D/A2023-06-20
13F-HR2023-05-15

View Matrix Capital Management Company, LP's complete filings history.

Compare quarters

Export Matrix Capital Management Company, LP's holdings